| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | United States | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | Japan | 1 | |
| #8 | Russian Federation | 1 | |
| #9 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Medical technology | |
| #5 | Surface technology and coating | |
| #6 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bello Gil Daniel | 4 |
| #2 | Costa Valles Cristina | 2 |
| #3 | Díaz Lagares Ángel | 2 |
| #4 | Larriba Bartolomé Sara | 2 |
| #5 | Pérez Cruz Magdiel | 2 |
| #6 | Hervás Marín David | 2 |
| #7 | Grinyó Boira Josep Maria | 2 |
| #8 | Luque Gómez Ana | 2 |
| #9 | Sandoval Del Amor Juan | 2 |
| #10 | Perez Cruz Magdiel | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3699300A1 | Seminal mirnas as non-invasive biomarkers for the diagnosis and/or prognosis of prostate cancer | |
| WO2019020634A2 | Beta-2 adrenergic agonists for the treatment of sistemic lupus erythematosous (sle) and sle-derived symptoms and manifestations | |
| US2019321322A1 | Nrf2 activators for the prevention and/or treatment of axonal degeneration | |
| EP3543358A1 | Methods and markers for azoospermia characterisation | |
| US2019032138A1 | Predictive methods of atherosclerosis and stenosis | |
| US2019203298A1 | Method and kit for the diagnosis of lung cancer |